Previous Article | Next Article ![]()
Infection and Immunity, August 2008, p. 3550-3560, Vol. 76, No. 8
0019-9567/08/$08.00+0 doi:10.1128/IAI.01613-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Novartis Vaccines, 53100 Siena, Italy
Received 6 December 2007/ Returned for modification 28 April 2008/ Accepted 26 May 2008
|
|
|---|
|
|
|---|
Putative virulence factors for GBS include filamentous appendages that extend from the bacterial cell surface, termed pili. Such structures have been implicated in mediating attachment to human epithelial cells (8) and in the binding and invasion of brain microvascular endothelial cells (21). Pili have also been reported in other gram-positive bacteria, including Corynebacterium diphtheriae (11, 37, 40) and members of the oropharyngeal microflora, such as Streptococcus pyogenes (27), Streptococcus pneumoniae (3), and Actinomyces naeslundii (10, 13). Similar to GBS, these structures facilitate adhesion to a variety of host tissues (1, 3, 22, 23, 41) and/or mediate interbacterial coaggregation (25). Furthermore, pilus proteins of GBS, S. pyogenes, and S. pneumoniae have all been shown to elicit a protective immune response in mouse models and are, hence, vaccine candidates against these important pathogens (12, 18, 20, 27).
The genes encoding pili in GBS are located within two distinct loci, denoted pilus islands 1 and 2 (PI-1 and PI-2), and comparative analyses of available genomes revealed two variants of PI-2, designated PI-2a and PI-2b (29). All, however, conform to the same basic organization (Fig. 1). Each PI comprises three genes encoding LPXTG family proteins, which constitute the physical pilus structure, along with two genes encoding transpeptidase enzymes associated with polymerization of the pilus protein subunits. The three pilus proteins of GBS are expressed as precursor polypeptides with an N-terminal signal peptide and a C-terminal cell wall sorting signal (29). One of these proteins, termed the "backbone" subunit, forms the shaft of the pilus, while the other two "ancillary" subunits appear intermittently in the structure.
![]() View larger version (22K): [in a new window] |
FIG. 1. Schematic representation of GBS PIs. Genes encoding the three LPXTG proteins that comprise the pilus structure are represented by black (backbone subunit) and white (ancillary subunits) arrows. Subfamily SrtC transpeptidases that polymerize the protein subunits are shown in gray. Gene designations correspond to GBS strain 2603V/R, accession number AE009948 (PI-1 and PI-2a) or strain COH1, accession number AAJR00000000 (PI-2b).
|
There is growing evidence that, in addition to the SrtC transpeptidases, the housekeeping SrtA may play some role in GBS pilus assembly. Nevertheless, the mechanism by which this might occur remained unclear. By comparing mutants defective in PI-associated sortases to those lacking SrtA, this study confirmed that, while not involved in pilus polymerization, SrtA is essential for the permanent anchoring of GBS pili to the cell wall. Moreover, a detailed analysis of PI-2a identified ancillary protein GBS150 as the substrate for SrtA and thus the anchor protein of these pilus structures. The work presented here, therefore, provides some of the first direct evidence as to the mechanism by which SrtA-mediated anchoring of pili can occur in GBS.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
Construction of in-frame deletion mutants. Standard recombinant DNA techniques were employed as described by Sambrook et al. (30). Plasmids (Table 1) were purified from E. coli cells using a Wizard Plus SV Miniprep System (Promega, Madison, WI). Oligonucleotides (Table 2) were synthesized in-house or by Invitrogen (Carlsbad, CA). Chromosomal DNA was prepared from mutanolysin-treated streptococcal cells using a Nucleospin Tissue Kit (Clontech, Mountain View, CA). PCRs were performed using GoTaq DNA polymerase as recommended by the manufacturer (Promega). PCR products were purified using the Wizard SV Gel/PCR Clean-Up System (Promega). DNA restriction and modification enzymes were used under the conditions specified by the manufacturer (NEB, Ipswich, MA).
|
View this table: [in a new window] |
TABLE 2. Primers used in this study
|
srtA. Transformation and allelic exchange were then performed as described previously (29). Confirmation of predicted insertions was obtained by PCR amplification and sequencing. To complement the srtA deletion mutant, a DNA fragment (796 bp) incorporating the entire srtA gene was PCR amplified from genomic DNA using primers srtAcomp.F and srtAcomp.R. This product was cloned into E. coli-streptococcal shuttle vector pAM401/gbs80P+T (29), generating plasmid pAM401-srtA. This construct was purified and used to transform S. agalactiae srtA mutants by electroporation. Complementation was confirmed by detection of srtA RNA transcript using the primers srttrans.F and srttrans.R. RNA extraction and cDNA synthesis were performed as described below. Empty pAM401/gbs80P+T without the srtA coding sequence was also used to transform wild-type and srtA mutant strains as controls for effects induced by vector alone.
RNA extraction and cDNA synthesis. Bacterial mid-exponential-phase cultures (6 ml) were stabilized using RNAprotect Bacteria Reagent (Qiagen, Hilden, Germany), according to manufacturer's instructions, and the cells were subsequently harvested (3,000 x g for 20 min at 4°C). Cells were incubated at 37°C for 10 min in Tris-EDTA buffer containing 15 mg ml–1 lysozyme and 100 U of mutanolysin and mixed with 350 µl of buffer RLT (RNeasy Mini Kit; Qiagen). RNA was then prepared using an RNeasy Mini Kit (Qiagen), according to manufacturer's instructions. The integrity of the RNA was confirmed by gel electrophoresis, and the RNA was then treated with DNase I (Promega) for 2 h at 37°C. The concentration of RNA was determined by measuring the A260 in a spectrophotometer. RNA (2 µg) was reverse transcribed into cDNA with random hexamer primers, as described previously (43). For each RNA sample, a control cDNA reaction in the absence of reverse transcriptase was performed to check for DNA contamination.
Immunoblotting. S. agalactiae strains were maintained at 37°C and 5% CO2 in either THB or chemically defined FMC medium. For total protein extracts, mid-exponential-phase cells were harvested, washed in phosphate-buffered saline (PBS) and resuspended in 50 mM Tris-HCl containing 400 U of mutanolysin. Cell suspensions were incubated at 37°C for 2 h and lysed by three cycles of freeze-thawing, and the cellular debris was removed (12,000 x g for 10 min). Supernatants were collected, and protein concentration was determined using a Bio-Rad protein assay (Hercules, CA). Proteins (20 µg) were resolved on 3 to 8% or 4 to 12% NuPage Novex sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels (Invitrogen) and transferred to nitrocellulose. Membranes were probed with mouse antiserum directed against LPXTG family or PI proteins (1:1,000 dilution), followed by a rabbit anti-mouse horseradish peroxidase-conjugated secondary antibody (Dako, Glostrup, Denmark). Bands were then visualized using an Opti-4CN substrate kit (Bio-Rad) or SuperSignal West Pico chemiluminescent substrate (Pierce, Rockford, IL).
To visualize proteins released during growth, culture supernatants were harvested (3,000 x g for 20 min), dialyzed extensively against distilled H2O and concentrated by lyophilization, before being subjected to SDS-PAGE, with 2 ml of supernatant equivalent loaded per well. Corresponding cell pellets were digested with mutanolysin, as described above, prior to dialysis and lyophilization.
Protein solubility in detergent. Bacterial cultures (10 ml) were grown to an optical density at 600 nm of 1.0, harvested (3,000 x g for 20 min), washed with PBS, and then adjusted to 1 x 109 cells ml–1 in 0.5 M Tris-HCl (pH 8), with or without 0.5% (wt/vol) SDS. Cell suspensions were incubated for 1.5 h at 25°C with gentle agitation. Supernatants were collected (3,000 x g for 20 min), dialyzed extensively against distilled H2O, and concentrated by lyophilization, before being subjected to SDS-PAGE, with 2 ml of supernatant equivalent loaded per well. Corresponding cell pellets were digested with mutanolysin prior to visualization by immunoblotting, as described above.
Flow cytometry. Following SDS treatment, as described above, harvested bacterial cells were resuspended in PBS containing 0.1% (wt/vol) paraformaldehyde. Cell suspensions were incubated at 37°C for 1 h, followed by an additional incubation at 25°C for 1 h. Fixed cells were then washed in PBS and incubated at 25°C for 20 min in newborn calf serum (Sigma, St. Louis, MO). Bacteria were then incubated for 1 h at 4°C with preimmune or immune serum diluted 1:200 in dilution buffer (PBS, 0.1% [wt/vol] bovine serum albumin, 20% [vol/vol] newborn calf serum). Cells were washed in PBS-0.1% (wt/vol) bovine serum albumin and incubated for a further 1 h with R-phycoerythrin-conjugated F(ab)2 goat anti-mouse immunoglobulin G (1:100 dilution) (Jackson ImmunoResearch Laboratories, West Grove, PA). Cells were washed again, resuspended in PBS, and analyzed with a FACSCalibur apparatus (Becton Dickinson, Franklin Lakes, NJ), using FlowJo software (Tree Star, Ashland, OR). The difference in mean fluorescence levels between preimmune and immune sera was calculated for each pilus protein.
|
|
|---|
![]() View larger version (79K): [in a new window] |
FIG. 2. Confirmation of S. agalactiae srtA mutant generation. (A) Transcription of srtA and flanking genes (gyrA, SAG0962, and SAG0963) in wild-type and srtA mutant strains. RNA was extracted from wild-type (wt), srtA deletion ( srtA) and complemented ( srtA+) strains, cDNA was synthesized, and the presence of transcripts was detected by PCR. Wild-type genomic DNA (50 ng) was used as a positive control, as indicated. DNA markers (bp) are given on the left-hand side. Schematic indicates positioning of primer sites. (B) Comparative growth of wild-type (filled squares) and srtA deletion (empty squares) and complemented strains (empty triangles), along with strain 515 (pAMp) as a complementation vector control (filled triangles). Bacteria were grown for 7 h at 37°C in 5% CO2 in THB medium, and the optical density at 600 nm was measured at the indicated times. (C) Western immunoblot analyses of wild-type and srtA mutant strains with antiserum against LPXTG family surface proteins. Total protein extracts (20 µg) were collected as described in Materials and Methods, blotted onto nitrocellulose, and probed with antisera directed against SAG0392, SAG0771, and SAG1462 (right panel). Extracts were also stained with Coomassie blue as a protein loading control (left panel). Molecular size markers (kDa) are indicated.
|
Effect of srtA mutation on pilus expression. To investigate the role of SrtA in pilus assembly, the first step was to examine overall levels of pilus expression in the srtA mutant compared to the wild type. Immunoblot analyses of total protein extracts revealed the expected high-molecular-weight laddering indicative of pilus-like structures (18). Comparison of these protein profiles indicated that whole-cell extracts of the srtA mutant possessed fewer pili than the wild type (Fig. 3A, upper panel). Using antiserum directed against each of the pilus proteins, pilus loss was found to involve the entire pilus structure, affecting the backbone protein, GBS59, and also the two ancillary proteins, GBS67 and GBS150. Complementation of the srtA mutation restored expression of all three pilus structural proteins to levels comparable to those of the wild type (Fig. 3A, upper panel). This was not seen for the srtA mutant transformed with an empty expression vector alone (data not shown). Thus, while not affecting the process of pilus polymerization, loss of SrtA appeared to result in a lower level of pili associated with the bacterial cells.
![]() View larger version (82K): [in a new window] |
FIG. 3. Relative abundance of pilus proteins associated with wild-type 515 and srtA mutant strains. (A) Proteins were collected from FMC culture supernatants or harvested cell pellets of wild-type 515 (wt) and srtA deletion ( srtA) and complemented ( srtA+) strains, blotted onto nitrocellulose, and probed with antiserum directed against each of the PI-2a pilus proteins (GBS59, GBS67, and GBS150). (B) Total protein extracts were also stained with Coomassie blue as protein loading controls. Molecular size markers (kDa) are indicated. (C) Transcription of PI-2a pilus protein subunits in wild-type and srtA mutant strains. RNA was extracted from wild-type (wt) and srtA deletion ( srtA) and complemented ( srtA+) strains; cDNA was synthesized, and the presence of backbone (GBS59) and ancillary (GBS67/GBS150) protein transcripts was detected by PCR. Wild-type genomic DNA (50 ng) was used as a positive control, as indicated. , anti.
|
Anchoring of pili by SrtA. Given the role of SrtA as a transpeptidase, studies progressed to determine if the pilus loss seen with the srtA mutants resulted from a failure of pili to be securely anchored to peptidoglycan of the bacterial cell wall. Proteins that are covalently attached to the cell wall will be unaffected by mild detergent treatment. By contrast, proteins that are held transiently within the cell membrane, as would be predicted for noncovalently bound pili in srtA mutant cells, will be susceptible to solubilization (17, 37, 38). Consequently, wild-type and srtA mutant cells were incubated with 0.5% SDS, and pilus loss was compared. No pilus loss occurred in the absence of SDS for any of the strains tested. Incubation of wild-type strain 515 with SDS resulted in barely detectable levels of pilus loss into the extracellular environment, possibly reflecting a very low-level lysis during the incubation step. Similarly, this background level of pilus release was seen for the srtA complemented mutant (Fig. 4A). By contrast, a pilus protein ladder was clearly detectable in the supernatant following SDS treatment of the srtA mutant (Fig. 4A). This pilus loss was further confirmed by fluorescence-activated cell sorting (FACS) analysis. A comparison of mean fluorescence values (comparing preimmune and immune sera) for backbone protein (GBS59) indicated a greater than 90% reduction in staining for the srtA mutant cells compared to the wild type (Fig. 4B). Similarly, staining of srtA mutant cells for ancillary protein 1 (GBS67) was 85% lower than that of wild-type cells (Fig. 4B). Levels were restored to those of the wild type for both protein subunits in the srtA complemented strain (Fig. 4B). As reported previously (29), surface staining was negative for ancillary protein 2 (GBS150). Taken together, these data imply that in the presence of SrtA, pili are tightly anchored to the cell wall of the bacteria, whereas in its absence, pili are only transiently held within the membrane and are therefore susceptible to release by detergent. The small fraction of cell-associated pili that are still detectable in the srtA mutant following SDS treatment may represent pili that have failed to be solubilized by the detergent or that are retained through interactions with other membrane components such as the PI-associated sortases.
![]() View larger version (36K): [in a new window] |
FIG. 4. Effects of mild detergent treatment on pilus anchoring by wild-type (wt) and srtA mutant strains. (A) Bacterial cells were incubated with (+) or without (–) 0.5% SDS for 1.5 h, and the supernatants were harvested. Proteins were then extracted as described in Materials and Methods, blotted onto nitrocellulose, and probed with antiserum directed against the pilus backbone protein (GBS59). (B) Flow cytometry analysis of bacterial cells. Cells were incubated with 0.5% SDS for 1.5 h, paraformaldehyde fixed, and then stained with antiserum against each of the three pilus proteins followed by an R-phycoerythrin secondary antibody. Filled histograms correspond to staining of bacteria with preimmune serum, while black histograms indicate staining with specific antiserum. The change in mean fluorescence is indicated in the top right-hand corner of each plot. wt, wild-type; srtA, srtA deletion mutant; srtA+, srtA complemented mutant; , anti.
|
![]() View larger version (41K): [in a new window] |
FIG. 5. Relative abundance of pilus proteins associated with sortase mutants (A) or pilus protein mutants (B) of PI-2a. Proteins were collected from FMC culture supernatants (lower panels) or harvested cell pellets (upper panels), as described in Materials and Methods, blotted onto nitrocellulose, and probed with antiserum directed against each of the pilus proteins (GBS59, GBS67, and GBS150). wt, wild-type; srtA, srtA deletion mutant; 1405 and 1406, pilus-associated sortase C family deletion mutants; 59, -67, and -150, pilus protein deletion mutants; , anti.
|
![]() View larger version (39K): [in a new window] |
FIG. 6. Effects of mild detergent treatment on sortase mutants (A) or pilus protein mutants (B) of PI-2a. Bacterial cells were incubated with (+) or without (–) 0.5% SDS for 1.5 h, and the supernatants were harvested. Proteins were then extracted as described in Materials and Methods, blotted onto nitrocellulose, and probed with antiserum directed against the pilus backbone protein (GBS59). wt, wild-type; srtA, srtA deletion mutant; 1405 and 1406, pilus-associated sortase C family deletion mutants; 59, -67, and -150, pilus protein deletion mutants.
|
![]() View larger version (49K): [in a new window] |
FIG. 7. Fate of ancillary protein GBS150 in the absence of SrtA or the pilus-associated SrtC transpeptidases. Bacterial cells were incubated with 0.5% SDS for 1.5 h, and the suspensions were subsequently separated into cell-associated (A) and extracellular (B) fractions. Proteins were extracted as described in Materials and Methods, blotted onto nitrocellulose, and probed with antiserum directed against ancillary protein GBS150. wt, wild-type; srtA, srtA deletion mutant; 1405 and 1406, pilus-associated sortase C family deletion mutants.
|
|
|
|---|
Loss of pili from the srtA mutant cell surface correlates well with the previous findings of Dramsi et al. (8), in which an srtA mutant in GBS strain NEM316 was shown by transmission electron microscopy to bear fewer pili on its surface than the wild type. However, in that study this observation was attributed to a down-regulation in transcription of the pilus protein genes and therefore failure to express protein subunits in the absence of SrtA. The present work, however, found no evidence to support this finding. By contrast, the extracellular release of significant quantities of pili by srtA mutants and the visible expression of protein monomers clearly demonstrated that pilus structures were formed. Based on these data, therefore, it would be predicted that the presence of fewer pili on the surface resulted from shedding into the extracellular environment. To further support a role for SrtA in the anchor phase of pilus assembly, cells were subjected to mild detergent treatment. Such a method is often employed with gram-positive bacteria to distinguish between proteins that are membrane associated (SDS soluble) and those that are covalently anchored to the peptidoglycan of the cell wall (SDS resistant) (17, 37, 38). In this way it was shown that pili fail to be covalently attached to the cell wall in the absence of SrtA but, rather, are held transiently in the cell membrane before being secreted into the extracellular environment. A similar finding has also been reported in C. diphtheriae, for which it was shown that in the absence of the SrtA homologue, SrtF, pili were shed into the culture medium and were more readily solubilized by boiling in SDS (33, 37).
Only the absence of ancillary subunit GBS150, either due to deletion of the gene itself or of the gene encoding the SrtC transpeptidase (SAG1406) required for GBS150 incorporation into the pilus, resulted in a profile of pilus loss that mimicked that of the srtA mutation. This implied, therefore, that GBS150 is the target of SrtA activity in pilus anchoring. Such a role could explain why surface staining for GBS150 by FACS is consistently negative (Fig. 4B) (29). Although at present we cannot say conclusively if this negative staining indicates that GBS150 is absent from the pilus shaft or that it is present but hidden from antibodies, one might predict that the anchor protein would be less accessible throughout the pilus structure than the other pilus subunits. Importantly, however, based on the model proposed here, inclusion of GBS150 within the pilus shaft and its role as the anchor are not mutually exclusive. Interestingly, FACS staining is also negative for GBS150 homologues from PI-1 and PI-2b (29), suggesting that these other PIs of GBS might also utilize an ancillary protein anchor. Furthermore, these data provide an explanation for the observation made by Dramsi et al. (8) that the GBS150 homologue in strain NEM316, GBS1474, was localized predominantly at the base of the pilus structure, as detected by immunogold electron microscopy.
The role of GBS150 as the pilus anchor is also supported by the sequence data. Based on the classification system proposed by Comfort and Clubb (5), subunits GBS59 and GBS67 both possess sortase recognition motifs that fit the classic family 3 (SrtC) motif (IPXTGG), while the motif of GBS150 is closer to that of SrtA (LPKTGM). Nevertheless, it is clear that GBS150 is also recognized by the SrtC transpeptidases as its incorporation into the pilus structure occurs even in the absence of SrtA. This implies, therefore, that elements in addition to the LPXTG motif may determine the specificity of sortase substrates. Data presented here suggest that a significant fraction of GBS150 monomer is not anchored to the bacterial cell wall, while in its polymerized form as a component of the pilus, GBS150 is securely attached. This implies that efficient SrtA anchoring of GBS150 to the cell wall only occurs following SrtC-mediated incorporation of GBS150 into the pilus structure. One might speculate, therefore, that it is a conformational change in GBS150 following polymerization that enables it to be recognized by SrtA. Alternatively, the monomeric form of GBS150 might be protected from SrtA by other proteins, such as the SrtC transpeptidases themselves, or by a chaperone protein, as was recently proposed for pilus assembly in group A Streptococcus (42). Such possibilities are currently under investigation.
The processes that govern the order for the uptake and inclusion of each pilus component remain unclear. However, observations that pilus length is greatly extended upon overexpression of the backbone subunit (18, 29, 37) imply that subunit stoichiometry may play at least some part in regulating overall pilus composition. As such, one might expect to find the anchor protein in lower abundance than those proteins that constitute the pilus shaft. That a pool of monomeric GBS150 was found within the cells, therefore, may support the notion that GBS150 can occur as both a pilus shaft component and as the pilus anchor. However, since it is not possible to quantify the relative abundance of each pilus protein by Western immunoblotting, this remains a question for future studies.
Taken together, these data can be used to expand on the recent models proposed for pilus assembly (24, 32-34). This process initiates with translocation of the pilus precursor subunits via the Sec system to the bacterial cell membrane, where they are retained by means of their C-terminal hydrophobic tails. Here, they are brought into close proximity with membrane-associated transpeptidases of both the SrtA and SrtC subfamilies. In contrast to C. diphtheriae, no initiating tip subunit has yet been found in GBS, but this and previous reports (29) have shown that it is the backbone subunit, GBS59, and, to a lesser extent, ancillary protein GBS67 that form the bulk of the pilus structure. SrtC enzymes, SAG1405 and SAG1406, therefore function to polymerize predominantly GBS59 and GBS67 subunits and in this way extend the pilus structure away from the bacterial cell surface. During this phase the growing pili interact with the membrane-associated SrtC enzymes, but these structures are not, however, covalently attached to the bacterial cell wall. For this to occur, SrtA is required. For SrtA to recognize and act upon pili, subunit GBS150 must be incorporated into the structure via its canonical pilin motif, predominantly by the action of sortase SAG1406. SrtA then cleaves GBS150 at its LPXTG motif and catalyzes its covalent attachment to peptidoglycan of the cell wall, thereby securely anchoring the pilus structures to the bacterial surface.
The model reported here relates specifically to PI-2a of GBS, and studies will now extend to PI-1 and PI-2b. Nevertheless, recent reports of SrtA-mediated pilus anchoring in C. diphtheriae (33) and Bacillus cereus (4) imply that this may be a common mechanism among gram-positive bacteria. Given the potential importance of pili to bacterial pathogenesis and vaccine strategies, elucidating these models in even greater detail will remain a priority.
This work was supported by Marie Curie Transfer of Knowledge Fellowship MTKD-CT-2004-509261.
Published ahead of print on 9 June 2008. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»